UNITED HEALTH PRODUCTS, INC. (OTCMKTS:UEEC) Files An 8-K Other Events
Item 8.01. Other Events
United Health Products Inc. (UEEC) has filed a FDA (Food and Drug
Administration) 510K Class II Application for expanded usage of
its patented HemoStyp products. The application will include
expanded usage into general surgeries and internal procedures.
HemoStyp Dressings are made from regenerated cotton cellulose,
treated with natural chemicals to become water soluble. When
contacting blood and exudates, the cellulose expands into a clear
gel, thereby adhering and creating pressure to seal the wound.
HemoStyp products are 50% cellulose and all natural. United
Health Products Inc. anticipates a response from the FDA within
90 days.
About UNITED HEALTH PRODUCTS, INC. (OTCMKTS:UEEC)
United Health Products, Inc. is a product development and solutions company. The Company develops, manufactures and markets hemostatic gauze for the healthcare and wound care sectors. The Company’s product, HemoStyp, is derived from regenerated oxidized cellulose and designed to absorb exudate/drainage from wounds and to help control bleeding. The Company is focused on identifying new markets and applications for its product. The Company has received orders from the dental and medical markets and is pursuing various markets for HemoStyp, including the medical, sports and veterinary sectors. Its HemoStyp Hemostatic Gauze is a hemostatic agent that controls bleeding from open wounds and body cavities. Its hemostatic gauze product line includes various configurations. Its hemostatic gauze product line includes dental gauze for oral surgery, approximately four versions of Trauma Gauze for battlefield trauma and approximately two island dressings to support intravenous procedures. UNITED HEALTH PRODUCTS, INC. (OTCMKTS:UEEC) Recent Trading Information
UNITED HEALTH PRODUCTS, INC. (OTCMKTS:UEEC) closed its last trading session up +0.0013 at 0.0750 with 190,832 shares trading hands.